NCT
HOME CURRENT ARCHIVE COVID-19
HOME CURRENT ARCHIVE PUBLISH INSTRUCTIONS
FOR AUTHORS COVID-19 LOG IN / REGISTER HISTORY ABOUT US DIRECTORY CONTACT
A therapeutic approach proposal for smoking cessation during hospitalization

Bedolla-Tinoco, Alan1; Ortíz-González, Yari G1; García-Peña, Luis E1; Thirión-Romero, Ireri1; Robles-Hernández, Robinson1; Hernández-Pérez, Andrea1; García-Gómez, Leonor1; Osio-Echanove, Jennifer1; Pérez-Padilla, Rogelio1





2024, Number 2

2024; 83 (2)






ABSTRACT

Smoking is a major public health issue stemming from nicotine addiction and the multi-organ damage caused by the toxic substances released during tobacco combustion. It has been described that during hospitalization, patients are more receptive to initiating smoking cessation treatment, taking advantage of the enforced abstinence due to the smoking ban in hospitals, with even greater effectiveness compared to standard treatment. Quitting smoking in hospitalized patients reduces the risk of infections, surgical wound bleeding, hospital stay length in patients diagnosed with pneumonia, the number of exacerbations in COPD patients, as well as acute coronary events. This review aims to formulate a management algorithm and provide recommendations based on the most up-to-date evidence regarding the treatment of tobacco addiction in the inpatient setting in our country. The initial evaluation involves assessing smoking consumption, level of motivation, nicotine dependence, and withdrawal symptoms. For patients with more than 6 months of abstinence, management is limited to verifying continued abstinence and preventing relapse. In contrast, those with less than 6 months of abstinence should be evaluated for withdrawal symptoms and receive both pharmacological treatment and brief counseling. Follow-up after discharge presents the main challenge, as many patients may experience immediate relapse or fail to return for further care. Therefore, healthcare services must have an established plan in place.

KEYWORDS

Smoking cessation treatment, hospitalization, cessation, nicotine withdrawal syndrome.

REFERENCES

  1. He H, Pan Z, Wu J, Hu C, Bai L, Lyu J. Health effects of tobacco at the global, regional, and national levels: results from the 2019 global burden of disease study. Nicotine Tob Res. 2022;24(6):864-870. Available in: https://pubmed.ncbi.nlm.nih.gov/34928373/

  2. INPRFM Psiquiatría IN de. Encodat Tabaco. Secretaría de Salud [Internet]. 2017, 489. Disponible en: https://www.gob.mx/salud%7Cconadic/acciones-y-programas/encuesta-nacional-de-consumo-de-drogas-alcohol-y-tabaco-encodat-2016-2017-136758

  3. Wendy M. The financial impact of smoking on health-related costs: a review of the literature. Am J Health Promot. 2001;15(5):321-331. Available in: https://pubmed.ncbi.nlm.nih.gov/11502013/

  4. Sari AA, Rezaei S, Arab M, Matin BK, Majdzadeh R. Does smoking status affect cost of hospitalization? Evidence from three main diseases associated with smoking in Iran. Med J Islam Repub Iran. 2017;31(1):63. Available in: https://pmc.ncbi.nlm.nih.gov/articles/PMC5804450/

  5. García-Gomez L, Robles-Hernández R, Hernández-Pérez A, Ossio-Echanove J, Thirion-Romero I, Pérez-Padilla R. Reporte breve sobre los síntomas de abstinencia a la nicotina y las características clínicas de los fumadores hospitalizados en un centro de referencia de tercer nivel. Ciudad de México; 2024. Disponible en: https://zenodo.org/records/10959803

  6. Khullar D, Maa J. The impact of smoking on surgical outcomes. J Am Coll Surg. 2012;215(3):418-426. Available in: https://journals.lww.com/journalacs/Fulltext/2012/09000/The_Impact_of_Smoking_on_Surgical_Outcomes.14.aspx

  7. Sørensen LT. Wound healing and infection in surgery. The clinical impact of smoking and smoking cessation: a systematic review and meta-analysis. Arch Surg. 2012;147(4):373-383. Available in: https://pubmed.ncbi.nlm.nih.gov/22508785/

  8. Mills E, Eyawo O, Lockhart I, Kelly S, Wu P, Ebbert JO. Smoking cessation reduces postoperative complications: a systematic review and meta-analysis. Am J Med. 2011;124(2):144-154. Available in: https://pubmed.ncbi.nlm.nih.gov/21295194/

  9. Jiménez RCA, de Granda OJI, Solano RS, Riesco MJA, de Higes ME, Pascual LJF, et al. Normativa sobre tratamiento del tabaquismo en pacientes hospitalizados. Arch Bronconeumol. 2017;53(7):387-394. Disponible en: https://www.archbronconeumol.org/en-normativa-sobre-tratamiento-del-tabaquismo-articulo-S0300289616303258

  10. Pleasants RA, Rivera MP, Tilley SL, Bhatt SP. Both duration and pack-years of tobacco smoking should be used for clinical practice and research. Ann Am Thorac Soc. 2020;17(7):804-806. Available in: articles/PMC7405110/

  11. Rigotti NA, Munafo MR, Stead LF. smoking cessation interventions for hospitalized smokers: a systematic review. Arch Intern Med. 2008;168(18):1950. Available in: /pmc/articles/PMC4500120/

  12. A clinical practice guideline for treating tobacco use and dependence: 2008 Update. A U.S. Public Health Service Report. Am J Prev Med. 2008;35(2):158-176. https://doi.org/10.1016/j.amepre.2008.04.009

  13. de Granda-Orive JI, Pascual-Lledó JF, Asensio-Sánchez S, Solano-Reina S, García-Rueda M, Martínez-Muñiz M, et al. Is the motivation to quit smoking a predictor of abstinence maintenance? Tob Prev Cessat. 2021;30(7):48. Available in: http://www.tobaccopreventioncessation.com/Is-the-motivation-to-quit-smoking-a-predictor-of-abstinence-maintenance-,136506,0,2.html

  14. Hendricks PS, Wood SB, Baker MR, Delucchi KL, Hall SM. The smoking abstinence questionnaire: measurement of smokers' abstinence-related expectancies. Addiction. 2011;106(4):716-728. Available in: /pmc/articles/PMC3348861/

  15. Shiffman S, Waters AJ, Hickcox M. The nicotine dependence syndrome scale: A multidimensional measure of nicotine dependence. Nicotine Tob Res. 2004;6(2):327-348. https://doi.org/10.1080/1462220042000202481

  16. Sharma MK, Sharma P. Need for validation of Fagerstrom test for nicotine dependence in Indian context: implications for nicotine replacement therapy. Indian J Psychol Med. 2016;38(2):105. Available in: /pmc/articles/PMC4820547

  17. Paz-Ballesteros WC, Zavala-Arciniega L, Gutiérrez-Torres DS, Ponciano-Rodríguez G, Reynales-Shigematsu LM. Evaluación de la dependencia física y psicológica al tabaco en fumadores mexicanos adultos, Encodat 2016. Salud Publica Mex. 2019;61(2):136-146. Disponible en: https://doi.org/10.21149/9858

  18. Villalobos-Gallegos L, Marín-Navarrete R, Templos-Nuñez L, Rosendo-Robles A. Nicotine craving questionnaire (CCN): psychometric properties on Mexican population. Salud Ment. 2012;35(4):273-277. Available in: http://www.scielo.org.mx/scielo.php?script=sci_abstract&pid=S0185-33252012000400002&lng=es&nrm=iso&tlng=en

  19. Germeroth LJ, Wray JM, Gass JC, Tiffany ST. Diagnostic utility of craving in predicting nicotine dependence: impact of craving content and item stability. Nicotine Tob Res. 2013;15(12):1988-1995. Available in: /pmc/articles/PMC3819973/

  20. Baker TB, Breslau N, Covey L, Shiffman S. DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5. Addiction (Abingdon, England). 2012;107(2):263. Available in: /pmc/articles/PMC3246568/

  21. Roberts C. The implications of noncompliance for randomized trials with partial nesting due to group treatment. Stat Med. 2020;40(2):349-368. https://doi.org/10.1002/sim.8778

  22. Balmford J, Borland R, Burney S. The role of prior quitting experience in the prediction of smoking cessation. Psychol Health. 2010;25(8):911-924. Available in: https://www.tandfonline.com/doi/abs/10.1080/08870440902866878

  23. Bailey SR, Bryson SW, Killen JD. Predicting successful 24-Hr quit attempt in a smoking cessation intervention. Nicotine & Tobacco Research. 2011;13(11):1092-1097. Available in: https://dx.doi.org/10.1093/ntr/ntr151

  24. García-Gómez L, Hernández-Pérez A, Noe-Díaz V, Riesco-Miranda JA, Jiménez-Ruiz C. Smoking cessation treatments: current psychological and pharmacological options. Rev Invest Clin. 2019;71(1):7-16. Available in: https://doi.org/10.24875/ric.18002629

  25. Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2016;2016(5):CD006103. Available in: https://pubmed.ncbi.nlm.nih.gov/27158893/

  26. Rigotti NA, Tindle HA, Regan S, Levy DE, Chang Y, Carpenter KM, et al. A post-discharge smoking-cessation intervention for hospital patients: helping hand 2 randomized clinical trial. Am J Prev Med. 2016;51(4):597-608. https://doi.org/10.1016/j.amepre.2016.04.005

  27. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2017;3(3):CD001292. Available in: https://pubmed.ncbi.nlm.nih.gov/28361496/

  28. Ross L. Never give up encouraging patients to give up smoking. Guidelines in Practice [Internet]. 2022. Available in: https://www.guidelinesinpractice.co.uk/smoking-cessation/very-brief-advice-can-be-effective-in-encouraging-smokers-to-quit/337163.article

  29. Asif A, Dailey H, Sheth HS, Petroulakis M. Enhancing hospitalists smoking cessation counseling and billing compliance by education intervention: a quality improvement project. J Community Hosp Intern Med Perspect. 2021;11(5):612-618. Available in: https://www.tandfonline.com/doi/abs/10.1080/20009666.2021.1961380

  30. Rigotti NA, Clair C, Munafò MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2012;5(5):CD001837. Available in: https://pubmed.ncbi.nlm.nih.gov/22592676/

  31. Sood A, Andoh J, Verhulst S, Ganesh M, Edson B, Hopkins-Price P. "Real-world" effectiveness of reactive telephone counseling for smoking cessation: a randomized controlled trial. Chest. 2009;136(5):1229-1236. Available in: https://pubmed.ncbi.nlm.nih.gov/19225061/

  32. Rutten LJF, Davis K, Squiers L, Augustson E, Blake K. Physician awareness and referral to national smoking cessation quitlines and web-based resources. J Cancer Educ. 2011;26(1):79. Available in: /pmc/articles/PMC3043326/

  33. Matkin W, Ordóñez-Mena JM, Hartmann-Boyce J. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2019;5(5):CD002850. Available in: https://pubmed.ncbi.nlm.nih.gov/31045250/

  34. Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y, Dobson R. Mobile phone text messaging and app-based interventions for smoking cessation. Cochrane Database Syst Rev. 2019;10(10):CD006611. Available in: https://pubmed.ncbi.nlm.nih.gov/31638271/

  35. Rábade-Castedo C, de Granda-Orive JI, Riesco-Miranda JA, De Higes-Martínez E, Ramos-Pinedo Á, Cabrera-César E, et al. Clinical practice guideline of spanish society of pneumology and thoracic surgery (SEPAR) on pharmacological treatment of tobacco dependence 2023. Arch Bronconeumol. 2023;59(10):651-661. https://doi.org/10.1016/j.arbres.2023.07.024

  36. Rigotti NA, Regan S, Levy DE, Japuntich S, Chang Y, Park ER, et al. Sustained care intervention and postdischarge smoking cessation among hospitalized adults: a randomized clinical trial. JAMA. 2014;312(7):719-728. Available in: https://pubmed.ncbi.nlm.nih.gov/25138333/

  37. Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018;2018(5):CD000146. Available in: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000146.pub5/full

  38. Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest. 2007;131(2):446-452. Available in: https://pubmed.ncbi.nlm.nih.gov/17296646/

  39. Theodoulou A, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J, Livingstone-Banks J, Hajizadeh A, Lindson N. What is the best way to use nicotine replacement therapy to quit smoking? Cochrane data base [Internet]. Cochrane Data Base. 2023;6:CD013308. Available in: https://www.cochrane.org/CD013308/TOBACCO_what-best-way-use-nicotine-replacement-therapy-quit-smoking

  40. Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2019;4(4):CD013308. Available in: https://doi.org/10.1002/14651858.cd013308

  41. Suissa K, Larivière J, Eisenberg MJ, Eberg M, Gore GC, Grad R, et al. Efficacy and safety of smoking cessation interventions in patients with cardiovascular disease: a network meta-analysis of randomized controlled trials. Circ Cardiovasc Qual Outcomes. 2017;10(1):e002458. Available in: https://pubmed.ncbi.nlm.nih.gov/28093398/

  42. Farber HJ, Leone FT, Cruz-Lopes L, EakiN MN, Evins AE, Evers-Casey S, et al. Initiating pharmacologic treatment in tobacco-dependent adults. an official american thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2020;202(2):e5-e31. Available in: http://www.atsjournals.org/doi/suppl/10.1164/rccm.202005-1982ST

  43. Chantix® (varenicline tartrate) Adverse Reactions | Pfizer Medical Information - US [Internet]. Available in: https://www.pfizermedicalinformation.com/chantix/adverse-reactions

  44. Raich A, Ballbe M, Nieva G, Cano M, Fernandez T, Bruguera E, et al. Safety of varenicline for smoking cessation in psychiatric and addicts patients. Subst Use Misuse. 2016;51(5):649-657. Available in: https://pubmed.ncbi.nlm.nih.gov/27050328/

  45. Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507-2520. Available in: https://pubmed.ncbi.nlm.nih.gov/27116918/

  46. Simon JA, Duncan C, Huggins J, Solkowitz S, Carmody TP. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial. Nicotine Tob Res. 2009;11(6):663-669. https://doi.org/10.1093/ntr/ntp047

  47. Richmond R, Zwar N. Review of bupropion for smoking cessation. Drug Alcohol Rev. 2003;22(2):203-220. Available in: https://onlinelibrary.wiley.com/doi/full/10.1080/09595230100100642

  48. Kinalp C, Kurultak I, Ceri M, Keskinel I. Serum creatinine elevation caused by bupropion. Wien Klin Wochenschr. 2009;126(3-4):138-139. https://doi.org/10.1007/s00508-013-0466-4

  49. Rigotti NA. Cytisine--a tobacco treatment hiding in plain sight. N Engl J Med. 2014;371(25):2429-2430. Available in: https://pubmed.ncbi.nlm.nih.gov/25517710/

  50. Jeong SH. Cytisine Pharmacokinetics and Dose Response (C-DRAKS 3 and C-DRAKS 4) - Full Text View - ClinicalTrials.gov [Internet]. 2019;49(11):1332-1337. Available in: https://clinicaltrials.gov/ct2/show/NCT02585024

  51. Courtney RJ, McRobbie H, Tutka P, Weaver NA, Petrie D, Mendelsohn CP, et al. Effect of cytisine vs varenicline on smoking cessation: a randomized clinical trial. JAMA. 2021;326(1):56-64. Available in: https://jamanetwork.com/journals/jama/fullarticle/2781643

  52. Karnieg T, Wang X. Cytisine for smoking cessation. CMAJ. 2018;190(19):e596. Available in: /pmc/articles/PMC5953578/

  53. Jeong SH, Sheridan J, Bullen C, Newcombe D, Walker N, Tingle M. Ascending single dose pharmacokinetics of cytisine in healthy adult smokers. Xenobiotica. 2018;49(11):1332-1337. Available in: https://www.tandfonline.com/doi/abs/10.1080/00498254.2018.1557760

  54. Manual 32. Manejo diagnóstico y tratamiento del tabaquismo en la práctica clínica diaria by SEPAR - Issuu [Internet]. 2015. Disponible en: https://issuu.com/separ/docs/manual_32

  55. Tian J, Venn A, Otahal P, Gall S. The association between quitting smoking and weight gain: a systematic review and meta-analysis of prospective cohort studies. Obes Rev. 2015;16(10):883-901. Available in: https://pubmed.ncbi.nlm.nih.gov/26114839/

  56. Japuntich SJ, Regan S, Viana J, Tymoszczuk J, Reyen M, Levy DE, et al. Comparative effectiveness of post-discharge interventions for hospitalized smokers: study protocol for a randomized controlled trial. Trials. 2012;13(1):1-13. Available in: https://trialsjournal.biomedcentral.com/articles/10.1186/1745-6215-13-124


2024, Number 2

2024; 83 (2)